Join

Compare · ICCC vs LMDX

ICCC vs LMDX

Side-by-side comparison of ImmuCell Corporation (ICCC) and LumiraDx Limited (LMDX): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ICCC and LMDX operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
  • LMDX is the larger of the two at $2.23B, about 35.8x ICCC ($62.4M).
  • ICCC has hit the wire 18 times in the past 4 weeks while LMDX has been quiet.
  • LMDX has more recent analyst coverage (4 ratings vs 0 for ICCC).
MetricICCCLMDX
Company
ImmuCell Corporation
LumiraDx Limited
Price
$8.39+8.96%
$0.02-53.80%
Market cap
$62.4M
$2.23B
1M return
+31.50%
-
1Y return
+52.55%
-
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Exchange
NASDAQ
NASDAQ
IPO
1987
News (4w)
18
0
Recent ratings
0
4
ICCC

ImmuCell Corporation

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. The company sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.